R1 RCM Inc. (NASDAQ: RCM) stock fell -0.13% on Thursday to $15.82 against a previous-day closing price of $15.84. With 2.26 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.31 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $15.99 whereas the lowest price it dropped to was $15.63. The 52-week range on RCM shows that it touched its highest point at $27.07 and its lowest point at $6.71 during that stretch. It currently has a 1-year price target of $19.56. Beta for the stock currently stands at 0.83.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RCM was down-trending over the past week, with a drop of -5.72%, but this was up by 4.01% over a month. Three-month performance surged to 12.20% while six-month performance rose 107.88%. The stock lost -25.24% in the past year, while it has gained 44.47% so far this year. A look at the trailing 12-month EPS for RCM yields -0.14 with Next year EPS estimates of 0.24. For the next quarter, that number is 0.00. This implies an EPS growth rate of -785.00% for this year and 469.77% for next year. EPS is expected to decline by -2.50% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -37.10%.
Float and Shares Shorts:
At present, 416.68 million RCM shares are outstanding with a float of 303.12 million shares on hand for trading. On Apr 27, 2023, short shares totaled 21.27 million, which was 5.09% higher than short shares on Mar 30, 2023. In addition to Mr. Lee Rivas as the firm’s CEO & Director, Mr. John M. Sparby serves as its Pres.
Through their ownership of 89.27% of RCM’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 34.29% of RCM, in contrast to 20.36% held by mutual funds. Shares owned by individuals account for 20.18%. As the largest shareholder in RCM with 3.57% of the stake, BlackRock Fund Advisors holds 14,868,353 shares worth 14,868,353. A second-largest stockholder of RCM, The Vanguard Group, Inc., holds 11,007,322 shares, controlling over 2.64% of the firm’s shares. Capital Research & Management Co is the third largest shareholder in RCM, holding 8,171,188 shares or 1.96% stake. With a 1.03% stake in RCM, the iShares Core S&P Mid Cap ETF is the largest stakeholder. A total of 4,289,117 shares are owned by the mutual fund manager. The American Century Heritage Fund, which owns about 0.94% of RCM stock, is the second-largest Mutual Fund holder. It holds 3,916,423 shares valued at 61.06 million. Calvert Small Cap Fund holds 0.80% of the stake in RCM, owning 3,330,498 shares worth 51.92 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, RCM reported revenue of $391.90M and operating income of $50.90M. The EBITDA in the recently reported quarter was $74.30M and diluted EPS was -$0.07.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for RCM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With RCM analysts setting a high price target of $26.00 and a low target of $16.00, the average target price over the next 12 months is $19.44. Based on these targets, RCM could surge 64.35% to reach the target high and rise by 1.14% to reach the target low. Reaching the average price target will result in a growth of 22.88% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded RCM stock several times over the past three months with 8 Buys and 0 Sells. In these transactions, 313,539 shares were bought while 0 shares were sold. The number of buy transactions has increased to 39 while that of sell transactions has risen to 29 over the past year. The total number of shares bought during that period was 5,891,217 while 158,813,067 shares were sold.